Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
transplant
Pharma
AZ touts Ultomiris results in post-transplant complication trial
Now that Ultomiris has matched the indications of its predecessor Soliris, AstraZeneca is eyeing new avenues for the C5 drug to make its mark.
Fraiser Kansteiner
Jun 16, 2025 10:32am
BMS's Orencia wins FDA nod for prevention of GVHD
Dec 15, 2021 3:25pm
BMS' Orencia snagged priority review in transplant rejection
Aug 23, 2021 11:02am
DaVita and Kidney Foundation spur living donors—and patient asks
Jun 23, 2021 8:25am
Incyte's faithful Jakafi ready to roll with brand-new indication
May 29, 2019 9:58am
PTx will hire 40 for U.S. Leukine plant it acquired from Sanofi
Mar 22, 2018 8:05am
